Mirum Pharmaceuticals (MIRM) Selling, General & Administrative (2019 - 2026)
Mirum Pharmaceuticals (MIRM) posted Selling, General & Administrative of $81.47 million for Q2 2026, up 28.7% from $63.29 million a year earlier but down 15.4% from the prior quarter.
Powered by 
Analysis
Mirum Pharmaceuticals (MIRM) Selling, General & Administrative (2019 - 2026) Analysis & Trends
For the trailing twelve months through Jun 30, 2026, Selling, General & Administrative at Mirum Pharmaceuticals was $313.84 million, up 37.4% year-over-year; for FY2025, it was $257.03 million, up 27.1% from FY2024.
- Annual Selling, General & Administrative has increased for six consecutive years, with a five-year compound annual growth rate of 62.5% (FY2020 to FY2025).
- In prior years, Mirum Pharmaceuticals' Selling, General & Administrative was $202.22 million in FY2024 (+38.6%), $145.88 million in FY2023 (+63.8%), $89.07 million in FY2022 (+50.4%) and $59.22 million in FY2021 (+161.0%).
- Quarterly Selling, General & Administrative has run from a low of $17.35 million in Q3 2021 to a high of $96.33 million in Q1 2026 over five years.
- On a year-over-year basis, Selling, General & Administrative has increased in each of the last 26 quarters, with growth averaging 33.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Selling, General & Administrative ranged from 22.5% (Q3 2025) to 202.7% (Q3 2021).
- According to Business Quant data, Selling, General & Administrative for the three prior quarters was $96.33 million (Q1 2026), $74.13 million (Q4 2025) and $61.91 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Mirum Pharmaceuticals | 5.37 Bn | 3.79 Bn | 145.90 Mn | 81.47 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 81.47 Mn |
| Mar 31, 2026 | 96.33 Mn |
| Dec 31, 2025 | 74.13 Mn |
| Sep 30, 2025 | 61.91 Mn |
| Jun 30, 2025 | 63.29 Mn |
| Mar 31, 2025 | 57.71 Mn |
| Dec 31, 2024 | 56.83 Mn |
| Sep 30, 2024 | 50.55 Mn |
| Jun 30, 2024 | 49.21 Mn |
| Mar 31, 2024 | 45.64 Mn |
| Dec 31, 2023 | 46.18 Mn |
| Sep 30, 2023 | 36.53 Mn |
| Jun 30, 2023 | 32.95 Mn |
| Mar 31, 2023 | 30.22 Mn |
| Dec 31, 2022 | 26.47 Mn |
| Sep 30, 2022 | 22.51 Mn |
| Jun 30, 2022 | 20.97 Mn |
| Mar 31, 2022 | 19.12 Mn |
| Dec 31, 2021 | 19.04 Mn |
| Sep 30, 2021 | 17.35 Mn |
API Access
Mirum Pharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MIRM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "MIRM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MIRM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();